Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21906607 | 0.92 | CYP4F2 (0.42) | CYP4F2CYP4A11TSHRTHRB | |
| SCHEMBL10970971 | 0.90 | CYP4F2 (0.40) | CYP4F2CYP4A11TSHR | |
| SCHEMBL17148450 | 0.85 | CYP4F2 (0.31) | CYP4F2CYP4A11TSHR | |
| SCHEMBL230727 | 0.83 | TSHR (0.38) | TSHRTHRB | |
| SCHEMBL1225944 | 0.83 | TSHR (0.46) | CYP4F2CYP4A11TSHRTHRB | |
| SCHEMBL22475307 | 0.83 | TSHR (0.41) | TSHRTHRB | |
| SCHEMBL19218033 | 0.79 | TSHR (0.34) | TSHRTHRB | |
| SCHEMBL5936572 | 0.78 | — | — | |
| SCHEMBL18534324 | 0.77 | TSHR (0.37) | CYP4F2CYP4A11TSHR | |
| SCHEMBL12907743 | 0.77 | CYP4F2 (0.39) | CYP4F2CYP4A11TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4547323-A | Synthesis of 2,2-dimethyl-4-methyleneglutaric acid and derivatives | SCM CORPORATION (US) | 1985-10-15 | — | — | US | claimed |
| US-9414996-B2 | Dental compositions comprising addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-08-16 | — | — | US | disclosed |
| US-9414996-B2 | Dental compositions comprising addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-08-16 | — | — | US | disclosed |
| US-9410030-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-08-09 | — | — | US | disclosed |
| US-9410030-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-08-09 | — | — | US | disclosed |
| US-20150283039-A1 | DENTAL COMPOSITIONS COMPRISING ADDITION-FRAGMENTATION AGENTS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2015-10-08 | — | — | US | disclosed |
| US-20150284538-A1 | ADDITION-FRAGMENTATION AGENTS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2015-10-08 | — | — | US | disclosed |
| US-20150284538-A1 | ADDITION-FRAGMENTATION AGENTS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2015-10-08 | — | — | US | disclosed |
| US-20150283039-A1 | DENTAL COMPOSITIONS COMPRISING ADDITION-FRAGMENTATION AGENTS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2015-10-08 | — | — | US | disclosed |
| WO-2014074427-A1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-05-15 | — | — | WO | disclosed |
| WO-2014074373-A1 | DENTAL COMPOSITIONS COMPRISING ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-05-15 | — | — | WO | disclosed |
| US-7022762-B2 | Method of emulsion polymerization | AGFA-GEVAERT (BE) | 2006-04-04 | — | — | US | disclosed |
| US-20060009574-A1 | Method of emulsion polymerization | AERT HUUB V | 2006-01-12 | — | — | US | disclosed |
| US-20050020787-A1 | Method of emulsion polymerization | E.I. DU PONT DE NEMOURS AND COMPANY | 2005-01-27 | — | — | US | disclosed |
| US-20040176527-A1 | Method of emulsion polymerization | BARCLAYS BANK PLC, AS COLLATERAL AGENT | 2004-09-09 | — | — | US | disclosed |
| EP-1217010-B1 | Method of emulsion polymerization | AGFA GEVAERT (BE) | 2004-08-18 | — | — | EP | disclosed |
| EP-1217010-A1 | Method of emulsion polymerization | Agfa-Gevaert (BE) | 2002-06-26 | — | — | EP | disclosed |
| US-20020072580-A1 | Method of emulsion polymerization | E.I. DU PONT DE NEMOURS AND COMPANY | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284538-A1 | ADDITION-FRAGMENTATION AGENTS | CPSF1, CPSF7, FGB | CYP4F2 331/4885CYP4A11 2063/4885TSHR 3918/4885 |
| US-20150283039-A1 | DENTAL COMPOSITIONS COMPRISING ADDITION-FRAGMENTATION AGENTS | RAD51, TUBA8, ERCC4 | CYP4F2 3834/4885CYP4A11 4406/4885TSHR 4850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.